Advertisement

Journal of Neurology

, 256:176 | Cite as

The management of amyotrophic lateral sclerosis

  • J. PhukanEmail author
  • O. Hardiman
REVIEW

Abstract

The terms amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND) refer to a condition characterized by motor system degeneration with relative preservation of other pathways. Although there have been advances in symptomatic treatment, ALS remains an incurable condition. Advances in ALS management prolong survival but simultaneously raise challenging ethical dilemmas for physicians, patients and their families. Here, we review current practice in the management of ALS including pharmacological treatment, nutritional management, respiratory care, and evolving strategies in the management of cognitive impairment.

Key words

amyotrophic lateral sclerosis motor neurone disease management 

References

  1. 1.
    Chancellor AM, Warlow CP (1992) Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 55:1106–1115PubMedCrossRefGoogle Scholar
  2. 2.
    Cronin S, Hardiman O, Traynor BJ (2007) Ethnic variation in the incidence of ALS: a systematic review. Neurology 68(13):1002–1007PubMedCrossRefGoogle Scholar
  3. 3.
    Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2:806–819PubMedCrossRefGoogle Scholar
  4. 4.
    Nelson LM (1995) Epidemiology of ALS. Clin Neurosci 3:327–331PubMedGoogle Scholar
  5. 5.
    Haley RW (2003) Excess incidence of ALS in young Gulf War veterans. Neurology 61:750PubMedGoogle Scholar
  6. 6.
    Horner RD, Kamins KG, Feussner JR, et al. (2003) Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 61:742PubMedGoogle Scholar
  7. 7.
    Weisskopf MG, O’Reilly EJ, Mc- Cullough ML, et al. (2005) Prospective study of military service and mortality from ALS. Neurology 64:32PubMedCrossRefGoogle Scholar
  8. 8.
    Armon C (2004) Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 62:1027PubMedGoogle Scholar
  9. 9.
    Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O (2003) Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry 74:1258–1261PubMedCrossRefGoogle Scholar
  10. 10.
    Chaudhuri KR, Crump S, al-Sarraj S, et al. (1995) The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study. J Neurol Sci 129 (Suppl):11PubMedCrossRefGoogle Scholar
  11. 11.
    Gallagher JP (1989) Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 80:114–117PubMedCrossRefGoogle Scholar
  12. 12.
    Isaacs JD, Dean AF, Shaw CE, et al. (2007) Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? J Neurol Neurosurg Psychiatry 78(7):750–753PubMedCrossRefGoogle Scholar
  13. 13.
    Pugdahl K, Fuglsang-Frederiksen A, de Carvalho M, et al. (2007) Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry 78(7):746–749PubMedCrossRefGoogle Scholar
  14. 14.
    Eisen A, Swash M (2001) Clinical neurophysiology of ALS. Clin Neurophysiol 112(12):2190–2201PubMedCrossRefGoogle Scholar
  15. 15.
    Leigh PN, Ray-Chaudhuri K (1994) Motor neuron disease. J Neurol Neurosurg Psychiatry 57:886–896PubMedCrossRefGoogle Scholar
  16. 16.
    Sumner AJ (1997) Consensus criteria for the diagnosis of partial conduction block and multifocal motor neuropathy. In: Kimura J Kaji R (eds) Physiology of ALS and related diseases, Elsevier, Amsterdam, pp 221–227Google Scholar
  17. 17.
    Kaji R (1999) Diagnosis and treatment of multifocal motor neuropathy (Lewis-Sumner). Rinsho Shinkeigaku 39:107–109PubMedGoogle Scholar
  18. 18.
    Komissarow L, Rollnik JD, Bogdanova D, et al. (2004) Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol 115(2):356–360PubMedCrossRefGoogle Scholar
  19. 19.
    Kuipers-Upmeijer J, de Jager AE, Hew JM, et al. (2001) Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry 71(5):615–620PubMedCrossRefGoogle Scholar
  20. 20.
    Miscio G, Pisano F, Mora G, et al. (1999) Motor neuron disease: usefulness of transcranial magnetic stimulation in improving the diagnosis. Clin Neurophysiol 110(5):975–981PubMedCrossRefGoogle Scholar
  21. 21.
    Chan S, Kaufmann P, Shungu DC, Mitsumoto H (2003) Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimaging Clin N Am 13:307–326PubMedCrossRefGoogle Scholar
  22. 22.
    Grosskreutz J, Peschel T, et al. (2008) Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders. Amyotroph Lateral Scler 9(4):238–248PubMedCrossRefGoogle Scholar
  23. 23.
    Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP (1996) Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 60:147–151PubMedCrossRefGoogle Scholar
  24. 24.
    Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O (2000) Amyotrophic Lateral Sclerosis Mimic Syndromes: A Population-Based Study. Arch Neurol 57:109–113PubMedCrossRefGoogle Scholar
  25. 25.
    Valdmanis PN, Rouleau GA (2008) Genetics of familial amyotrophic lateral sclerosis. Neurology 70(2):144–152PubMedCrossRefGoogle Scholar
  26. 26.
    Cronin S, Berger S, Ding J, Schymick JC, Washecka N, Hernandez DG, Greenway MJ, Bradley DG, Traynor BJ, Hardiman O (2008) A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet 17(5):768–774PubMedCrossRefGoogle Scholar
  27. 27.
    Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM-Y (2006) Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Vol. 314. no. 5796, pp 130–133Google Scholar
  28. 28.
    Arai T, Hasegawa M, Akiyama H, et al. (2006) TDP-43 is a component of ubiquitin- positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602–611PubMedCrossRefGoogle Scholar
  29. 29.
    Van Deerlin VM, Leverenz JB, Bekris LM, et al. (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histological analysis. Lancet Neurology 7:416Google Scholar
  30. 30.
    Sreedharan J, Blair IP, Tripathi VB, et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672PubMedCrossRefGoogle Scholar
  31. 31.
    Kabashi E, Valdmanis PN, Dion P, et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40(5):572–574PubMedCrossRefGoogle Scholar
  32. 32.
    Gitcho MA, Baloh RH, Chakraverty S, et al. (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63:535–538PubMedCrossRefGoogle Scholar
  33. 33.
    Strong MJ (2008) The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 9(6):323–338PubMedCrossRefGoogle Scholar
  34. 34.
    Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B, EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis (2005) EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 12(12):921–938PubMedCrossRefGoogle Scholar
  35. 35.
    Miller RG, Rosenberg JA, Gelinas DF, et al. (1999) Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52:1311PubMedGoogle Scholar
  36. 36.
    Chio A, Bottacchi E, Buffa C, Mutani R, Mora G, and the PARALS (2006) Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 77(8):948–950PubMedCrossRefGoogle Scholar
  37. 37.
    Miller RG, Mitchell JD, Lyon M, Moore DH (2002) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev; CD001447Google Scholar
  38. 38.
    Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML (2008) Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 105:2052–2057PubMedCrossRefGoogle Scholar
  39. 39.
    Meininger V, Shefner J, Cudkowicz M (2008) Lithium therapy in ALS. Amyotroph Lateral Scler 9(2):122PubMedCrossRefGoogle Scholar
  40. 40.
    Gordon PH, et al. (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: A phase III randomised trial. Lancet Neurol 6:1045PubMedCrossRefGoogle Scholar
  41. 41.
    Lanka V, Cudkowicz M (2008) Therapy development for ALS: lessons learned and path forward. Amyotroph Lateral Scler 9(3):131–140PubMedCrossRefGoogle Scholar
  42. 42.
    Borasio GD, Voltz R, Miller RG (2001) Palliative care in amyotrophic lateral sclerosis. Neurol Clin 19:829PubMedCrossRefGoogle Scholar
  43. 43.
    Schiffer RB, Herndon RM, Rudick RA (1985) Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 312:1480PubMedGoogle Scholar
  44. 44.
    Brooks BR, Thisted RA, Appel SH, et al. (2004) Treatment of pseudobulbar affect in ALS with dextromethorphan/ quinidine: a randomized trial. Neurology 63:1364PubMedGoogle Scholar
  45. 45.
    Bourke SC, Shaw PJ, Gibson GJ (2001) Respiratory function vs sleep-disordered breathing as predictors of QoL in ALS. Neurology 57:2040–2044PubMedGoogle Scholar
  46. 46.
    Lyall RA, Donaldson N, Polkey MI, et al. (2001) Respiratory muscle strength and ventilatory failure in ALS. Brain 124:2000–2013PubMedCrossRefGoogle Scholar
  47. 47.
    Stefanutti D, Benoist MR, Scheinmann P, et al. (2000) Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med 162:1507PubMedGoogle Scholar
  48. 48.
    Morgan RK, McNally S, Alexander M, et al. (2005) Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 171:269–274PubMedCrossRefGoogle Scholar
  49. 49.
    Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5(2):140–147PubMedCrossRefGoogle Scholar
  50. 50.
    Mustfa N, Walsh E, Bryant V, et al. (2006) The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology 66:1211PubMedCrossRefGoogle Scholar
  51. 51.
    Newson-Davis IC, Lyall RA, Leigh PN, et al. (2001) The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in ALS: a prospective study. J Neurol Neurosurg Psychiatry 71:482–487CrossRefGoogle Scholar
  52. 52.
    Aboussouan LS, Khan SU, Meeker DP, et al. (1997) Effect of noninvasive positive- pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 127:450–453PubMedGoogle Scholar
  53. 53.
    Gelinas D (2000) ALS and invasive ventilation. In: Oliver D, Borasio GD, Walsh D (eds) Palliative care in amyotrophic lateral sclerosis. Oxford: Oxford University Press, pp 56–62Google Scholar
  54. 54.
    Borasio GD, Gelinas DF, Yanagisawa N (1998) Mechanical ventilation in ALS: a cross-cultural perspective. J Neurol 245:S7–S12PubMedCrossRefGoogle Scholar
  55. 55.
    Leigh PN, Abrahams S, Al-Chalabi A, Ampong MA, Goldstein LH, Johnson J, Lyall R, Moxham J, Mustfa N, Rio A, Shaw C, Willey E; King’s MND Care and Research Team (2003) The management of motor neurone disease. J Neurol Neurosurg Psychiatry 74 (Suppl 4):iv32–iv47PubMedGoogle Scholar
  56. 56.
    Bradley MD, Orrell RW, Clarke J, et al. (2002) Outcome of ventilatory support for acute respiratory failure in motor neurone disease. J Neurol Neurosurg Psychiatry 72:752–756PubMedCrossRefGoogle Scholar
  57. 57.
    Polkey MI, Lyall RA, Green M, et al. (1999) Expiratory muscle function in ALA. Am J Resp Crit Care Med 158:734–741Google Scholar
  58. 58.
    Mustfa NM, Moxham J (2001) Respiratory muscle assessment in motor neurone disease. QJM 94:497–502PubMedCrossRefGoogle Scholar
  59. 59.
    Stambler N, Charatan M, Cedarbaum JM (1998) Prognostic indicators of survival in ALS. ALS CNTF study group. Neurology 50:66–72PubMedGoogle Scholar
  60. 60.
    Mazzini L, Corra T, Zaccala M, et al. (1995) Percutaneous endoscopic gastrostomy and enteral nutrition in ALS. J Neurol 242:695–698PubMedCrossRefGoogle Scholar
  61. 61.
    Forbes R, Colville S, Swingler R (2004) Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease. J Neurol 251:813–817PubMedCrossRefGoogle Scholar
  62. 62.
    Kasaskis EJ, Scarlata D, Hill R, et al. (1999) A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 169:118–125CrossRefGoogle Scholar
  63. 63.
    Boitano LJ, Jordan T, Benditt JO (2001) Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS. Neurology 56(3):413–414PubMedGoogle Scholar
  64. 64.
    Bello-Haas VD, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, Pioro EP, Mitsumoto H (2007) A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 68(23):2003–2007PubMedCrossRefGoogle Scholar
  65. 65.
    Rabkin JG, Albert SM, Del Bene ML, O’Sullivan I, Tider T, Rowland LP, Mitsumoto H (2005) Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 65:62–67PubMedCrossRefGoogle Scholar
  66. 66.
    Albert SM, Rabkin JG, Del Bene ML, et al. (2005) Wish to die in end-stage ALS. Neurology 65:68PubMedCrossRefGoogle Scholar
  67. 67.
    Gauthier A, Vignola A, Calvo A, Cavallo E, Moglia C, Sellitti L, Mutani R, Chio A (2007) A longitudinal study on quality of life and depression in ALS patientcaregiver couples. Neurology 68(12):923–926PubMedCrossRefGoogle Scholar
  68. 68.
    McDonald ER, Wiedenfeld SA, Hillel A, et al. (1994) Survival in amyotrophic lateral sclerosis. The role of psychological factors. Arch Neurol 51:17PubMedGoogle Scholar
  69. 69.
    Phukan J, Pender N, Hardiman O (2007) A Review of Cognitive Impairment in ALS. Lancet Neurol 6(11):994–1003PubMedCrossRefGoogle Scholar
  70. 70.
    Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B (2003) Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60:1094–1097PubMedGoogle Scholar
  71. 71.
    Barson FP, Kinsella GJ, Ong B, Mathers SE (2000) A neuropsychological investigation of dementia in motor neurone disease (MND). J Neurol Sci 180(1–2):107–113PubMedCrossRefGoogle Scholar
  72. 72.
    Geser NJ, Brandmeir LK, Kwong M, Martinez-Lage L, Elman L, McCluskey SX, Xie V, Lee M-Y, Trojanowski JQ (2008) Evidence of Multisystem Disorder in Whole-Brain Map of Pathological TDP-43 in Amyotrophic Lateral Sclerosis. F. Arch Neurol 65:636–641PubMedCrossRefGoogle Scholar
  73. 73.
    Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, Kohn MA, Lomen-Hoerth C (2005) The effects of executive and behavioural dysfunction on the course of ALS. Neurology 65:1774–1777Google Scholar
  74. 74.
    Mathuranath PS, Nestor P, Berrios GE, et al. (2000) A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology 55:1613–1620PubMedGoogle Scholar
  75. 75.
    Perry RJ, Miller B (2001) Behaviour and treatment in frontotemporal dementia. Neurology 56:S46–S51PubMedGoogle Scholar
  76. 76.
    Hecht MJ, Graesel E, Tigges S, et al. (2003) Burden of care in amyotrophic lateral sclerosis. Palliat Med 17:327–333PubMedCrossRefGoogle Scholar
  77. 77.
    Chio A, Gauthier A, Calvo A, et al. (2005) Caregiver burden and patients’ perception of being a burden in ALS. Neurology 64(10):1780–1782PubMedCrossRefGoogle Scholar
  78. 78.
    de Carvalho M, Dengler R, Eisen A, et al. (2007) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119(3):497–503PubMedCrossRefGoogle Scholar
  79. 79.
    Baekand WS, Desai NP (2007) ALS: Pitfalls in the Diagnosis. Practical Neurology 7:74–81Google Scholar
  80. 80.
    Sejvar JJ, Holman RC, Bresee JS, et al. (2005) ALS mortality in the United States 1997–2001. Neuroepidemiology 25(3):144–152PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff-Verlag 2009

Authors and Affiliations

  1. 1.Dept. of NeurologyBeaumont HospitalDublin 9Ireland
  2. 2.Trinity College Institute of NeuroscienceDublin 9Ireland

Personalised recommendations